Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Influence of Olfaction Essential Oils on the Consumption of Benzodiazepine Receptor Agonists & Z-Drugs (BZRAs) Prescribed as " if Needed " in Psychiatric Outpatients (HECBA-PSY).

NCT05583240 is registered in ClinicalTrials.gov with Etablissement Public de Santé Barthélemy Durand as lead sponsor.

NCT NCT05583240
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT05583240 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Influence of Olfaction Essential Oils on the Consumption of Benzodiazepine Receptor Agonists & Z-Drugs (BZRAs) Prescribed as " if Needed " in Psychiatric Outpatients (HECBA-PSY).
Lead sponsor
Etablissement Public de Santé Barthélemy Durand
Phase
Phase 4
Overall status
Unknown status
Start date
April 19, 2021
Completion date
July 30, 2023
Enrollment
50 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

benzodiazepine withdrawal, psychiatric disorder